153 related articles for article (PubMed ID: 17239912)
1. Fluorescent tracking of nickel ions in human cultured cells.
Ke Q; Davidson T; Kluz T; Oller A; Costa M
Toxicol Appl Pharmacol; 2007 Feb; 219(1):18-23. PubMed ID: 17239912
[TBL] [Abstract][Full Text] [Related]
2. Nickel carcinogenesis: epigenetics and hypoxia signaling.
Costa M; Davidson TL; Chen H; Ke Q; Zhang P; Yan Y; Huang C; Kluz T
Mutat Res; 2005 Dec; 592(1-2):79-88. PubMed ID: 16009382
[TBL] [Abstract][Full Text] [Related]
3. Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture.
Costa M; Simmons-Hansen J; Bedrossian CW; Bonura J; Caprioli RM
Cancer Res; 1981 Jul; 41(7):2868-76. PubMed ID: 7248947
[TBL] [Abstract][Full Text] [Related]
4. Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles.
Sen P; Costa M
Cancer Res; 1985 May; 45(5):2320-5. PubMed ID: 3986775
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel.
Abbracchio MP; Simmons-Hansen J; Costa M
J Toxicol Environ Health; 1982 Apr; 9(4):663-76. PubMed ID: 7108981
[TBL] [Abstract][Full Text] [Related]
6. Ultrafine NiO particles induce cytotoxicity in vitro by cellular uptake and subsequent Ni(II) release.
Horie M; Nishio K; Fujita K; Kato H; Nakamura A; Kinugasa S; Endoh S; Miyauchi A; Yamamoto K; Murayama H; Niki E; Iwahashi H; Yoshida Y; Nakanishi J
Chem Res Toxicol; 2009 Aug; 22(8):1415-26. PubMed ID: 19630433
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the toxicity induced by nickel soluble and particulate forms in human airway epithelial cells.
Forti E; Salovaara S; Cetin Y; Bulgheroni A; Tessadri R; Jennings P; Pfaller W; Prieto P
Toxicol In Vitro; 2011 Mar; 25(2):454-61. PubMed ID: 21111804
[TBL] [Abstract][Full Text] [Related]
8. Alterations of histone modifications and transgene silencing by nickel chloride.
Ke Q; Davidson T; Chen H; Kluz T; Costa M
Carcinogenesis; 2006 Jul; 27(7):1481-8. PubMed ID: 16522665
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity assessment of water-soluble nickel compounds.
Goodman JE; Prueitt RL; Dodge DG; Thakali S
Crit Rev Toxicol; 2009; 39(5):365-417. PubMed ID: 19514913
[TBL] [Abstract][Full Text] [Related]
11. In vitro electron microprobe of carcinogenic nickel compound interaction with tumor cells.
Berry JP; Poupon MF; Judde JC; Galle P
Ann Clin Lab Sci; 1985; 15(2):109-20. PubMed ID: 3994286
[TBL] [Abstract][Full Text] [Related]
12. Hazard identification and dose response of inhaled nickel-soluble salts.
Haber LT; Erdreicht L; Diamond GL; Maier AM; Ratney R; Zhao Q; Dourson ML
Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):210-30. PubMed ID: 10854127
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and biological attributes of nickel compounds in relationship to carcinogenic activities.
Sunderman FW
J UOEH; 1987 Mar; 9 Suppl():84-94. PubMed ID: 3602750
[TBL] [Abstract][Full Text] [Related]
14. Influence of surface charge and dissolution on the selective phagocytosis of potentially carcinogenic particulate metal compounds.
Heck JD; Costa M
Cancer Res; 1983 Dec; 43(12 Pt 1):5652-6. PubMed ID: 6640519
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics of nickel in rats after intratracheal administration of a soluble and insoluble form.
English JC; Parker RD; Sharma RP; Oberg SG
Am Ind Hyg Assoc J; 1981 Jul; 42(7):486-92. PubMed ID: 7246426
[TBL] [Abstract][Full Text] [Related]
16. Novel fluorescence assay for tracking molecular and cellular allergen-protein interactions.
Thierse HJ; Helm S; Pink M; Weltzien HU
J Immunol Methods; 2007 Dec; 328(1-2):14-20. PubMed ID: 17880993
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability, intracellular mobilization of nickel, and HIF-1α activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles.
Pietruska JR; Liu X; Smith A; McNeil K; Weston P; Zhitkovich A; Hurt R; Kane AB
Toxicol Sci; 2011 Nov; 124(1):138-48. PubMed ID: 21828359
[TBL] [Abstract][Full Text] [Related]
18. [Toxicity and carcinogenicity of nickel and its compounds. A review of the current status (author's transl)].
Raithel HJ; Schaller KH
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 173(1-2):63-91. PubMed ID: 6455890
[TBL] [Abstract][Full Text] [Related]
19. Electron microprobe in vitro study of interaction of carcinogenic nickel compounds with tumour cells.
Berry JP; Galle P; Poupon MF; Pot-Deprun J; Chouroulinkov I; Judde JG; Dewally D
IARC Sci Publ; 1984; (53):153-64. PubMed ID: 6099827
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenicity assessment of selected nickel compounds.
Oller AR; Costa M; Oberdörster G
Toxicol Appl Pharmacol; 1997 Mar; 143(1):152-66. PubMed ID: 9073603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
